Clinical Trials Browser

Phase 4 × Recruiting × Ipilimumab × Clear all

NCT07504796 2026-04-21

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

Phase 4 Recruiting

Melanoma

NCT06031233 2026-03-30

MINUTE

Phase 4 Recruiting

Neoplasms